Veradermics, Inc
NYSE: MANE
- Raised $30 million (2026)
- 5 clinical trials, 4 active
- Founded 2021
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Vergent Bioscience, Inc.
- Raised $19 million (2025)
- 3 clinical trials, 1 active
- Research grants: $4 million
- Founded 2013
Epicore Biosystems, Inc.
- Raised $26 million (2025)
- 1 FDA-registered device site
- Research grants: $1.1 million
- Founded 2017
Zoll Medical Corp
- 35 clinical trials, 5 active
- FDA-cleared or approved devices
Genzyme Corp
- FDA-cleared or approved devices
- 2 FDA-registered drug sites
- Research grants: $861,433
Photopharmics Inc
- Raised $26 million (2025)
- 4 clinical trials
- Research grants: $1.3 million
ArunA Bio, Inc.
- Raised $13 million (2019)
- 1 clinical trial, 1 active
- Research grants: $14 million
DENTSPLY SIRONA Inc.
Nasdaq: XRAY
- FDA-cleared or approved devices
- 1 FDA-registered drug site
Oric Pharmaceuticals, Inc.
Nasdaq: ORIC
- Raised $125 million (2025)
- 10 clinical trials, 4 active
Amicus Therapeutics, Inc.
- Raised $30 million (2023)
- 46 clinical trials, 7 active
Aridis Pharmaceuticals, Inc.
- Raised $4.8 million (2022)
- 6 clinical trials
- Research grants: $5.4 million
binx health Ltd
- Raised $104 million (2021)
- 1 clinical trial
- FDA-cleared or approved devices
- Founded 2005
LumiThera, Inc.
- Raised $2 million (2019)
- 6 clinical trials, 2 active
- Research grants: $12 million
- Founded 2013
Madrigal Pharmaceuticals, Inc.
Nasdaq: MDGL
- Raised $35 million (2017)
- 20 clinical trials, 7 active
- Founded 2011
Orthopediatrics Corp
Nasdaq: KIDS
- Raised $39 million (2014)
- FDA-cleared or approved devices
- Founded 2007
Perfusio Corp.
- Raised $2.2 million (2024)
- 1 clinical trial
- Research grants: $5.1 million
- Founded 2014
Bristol Myers Squibb Co
NYSE: BMY
- 1800 clinical trials, 216 active
- 5 FDA-registered drug sites
AEON Biopharma, Inc.
NYSE: AEON
- Raised $30 million (2022)
- 4 clinical trials
- Founded 2012
Aurinia Pharmaceuticals Inc.
Nasdaq: AUPH
- Raised $52 million (2014)
- 19 clinical trials, 2 active
- Founded 2009
CytoAgents, Inc.
- Raised $7 million (2023)
- 1 clinical trial, 1 active
- Research grants: $15 million
- Founded 2018
Dyne Therapeutics, Inc.
Nasdaq: DYN
- Raised $116 million (2020)
- 4 clinical trials, 4 active
- Founded 2017
Enliven Therapeutics, Inc.
Nasdaq: ELVN
- Raised $90 million (2024)
- 4 clinical trials, 4 active
- Founded 2016
Nuvation Bio Inc.
NYSE: NUVB
- Raised $275 million (2020)
- 19 clinical trials, 9 active
- Founded 2018
Quoin Pharmaceuticals Ltd.
Nasdaq: QNRX
- Raised $105 million (2025)
- 4 clinical trials, 4 active
- Founded 2018
Rein Therapeutics, Inc.
Nasdaq: RNTX
- Raised $18 million (2023)
- 9 clinical trials, 1 active
Taysha Gene Therapies, Inc.
Nasdaq: TSHA
- Raised $150 million (2023)
- 4 clinical trials, 3 active
- Founded 2019
Personal Genome Diagnostics Inc.
- Raised $98 million (2021)
- FDA-cleared or approved devices
- Research grants: $1.2 million
- Founded 2015
Alaunos Therapeutics, Inc.
Nasdaq: TCRT
- Raised $20 million (2019)
- 37 clinical trials
C2N Diagnostics, LLC
- Raised $10 million (2025)
- 4 clinical trials
- Research grants: $5.1 million
Pacific Diabetes Technologies, Inc.
- Raised $3.4 million (2025)
- 2 clinical trials
- Research grants: $4.3 million
- Founded 2021
Aldeyra Therapeutics, Inc.
Nasdaq: ALDX
- Raised $10 million (2019)
- 35 clinical trials, 1 active
Atsena Therapeutics, Inc.
- Raised $90 million (2025)
- 2 clinical trials, 2 active
- Research grants: $2.5 million
- Founded 2019
Grace Therapeutics, Inc.
Nasdaq: GRCE
- Raised $15 million (2025)
- 8 clinical trials, 1 active
Intelligent Hearing Systems Corp
- 2 clinical trials
- FDA-cleared or approved devices
- Research grants: $16 million
Latigo Biotherapeutics, Inc.
Nasdaq: LTGO
- Raised $50 million (2025)
- 8 clinical trials, 1 active
Praxis Precision Medicines, Inc.
Nasdaq: PRAX
- Raised $10 million (2019)
- 17 clinical trials, 8 active
- Founded 2015
Renovion, Inc.
- Raised $15 million (2023)
- 2 clinical trials, 1 active
- Research grants: $3.6 million
- Founded 2013
Scion Neurostim, Inc.
- Raised $10 million (2023)
- 11 clinical trials, 1 active
- Research grants: $2 million
- Founded 2021
Theriva Biologics, Inc.
NYSE: TOVX
- Raised $13 million (2025)
- 8 clinical trials, 1 active
Capsulomics, Inc.
- Raised $2.4 million (2025)
- 1 clinical trial
- Research grants: $6.8 million
- Founded 2018
Mesoblast Ltd
Nasdaq: MESO
- Raised $6.5 million (2020)
- 34 clinical trials, 2 active
Revvity, Inc.
NYSE: RVTY
- Raised $2.2 billion (2021)
- FDA-cleared or approved devices
Venus Concept Inc.
OTC: VERO
- Raised $1.5 million (2026)
- 34 clinical trials, 2 active
Palvella Therapeutics, Inc.
Nasdaq: PVLA
- Raised $9.7 million (2022)
- 16 clinical trials, 5 active
- Founded 2013
Anebulo Pharmaceuticals, Inc.
OTC: ANEB
- Raised $15 million (2024)
- 3 clinical trials, 1 active
- Founded 2020
BioAge Labs, Inc.
Nasdaq: BIOA
- Raised $194 million (2024)
- 7 clinical trials, 2 active
CRISPR Therapeutics AG
Nasdaq: CRSP
- Raised $1 million (2020)
- 20 clinical trials, 10 active
- Founded 2013
DiaMedica Therapeutics Inc.
Nasdaq: DMAC
- Raised $30 million (2025)
- 7 clinical trials, 1 active
Dynocardia, Inc.
- Raised $4.8 million (2025)
- 1 clinical trial, 1 active
- Research grants: $10 million
- Founded 2018
Immunic, Inc.
Nasdaq: IMUX
- Raised $200 million (2026)
- 7 clinical trials, 3 active
Published company profiles only; counts update daily. Data licences